Valeant’s stock soars as investors cheer poaching of Zoetis CFO

Valeant Pharmaceuticals’ stock soared after it poached its new CFO from Zoetis--Bill Ackman’s hedge fund Pershing Square Capital Management is a large shareholder of both companies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.